Dr. Corey L. Hartman tells ESSENCE how this prescription can have long-term effects not just the body—but also on our skin.
Early and accurate diagnosis is crucial in skin cancer, ensuring patients receive the right treatment with access to a suite of effective therapies. The five-year survival rate for melanoma is almost ...
Anti-C1q antibodies are highly prevalent among patients with IgG4-RD, particularly those with renal and skin manifestations.
Sanofi SNY and partner Regeneron REGN announced that the FDA has accepted their supplemental biologics license application ...
Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedi ...
These are the first approvals of nemolizumab from countries within the Access Consortium framework, with regulatory review processes ongoing in the ...